FDA recall record

Revive Rx LLC dba Revive Rx Pharmacy Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL recall — FDA D-0511-2024

Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate

Class Iclassification
D-0511-2024official record ID
Jun 5, 2024report date

Recall record at a glance

Official recordD-0511-2024
CategoryDrug Recalls
ClassificationClass I
FDA record statusOngoing
Recalling firmRevive Rx LLC dba Revive Rx Pharmacy
Report dateJun 5, 2024
Recall initiation dateApr 20, 2024
Quantity751 vials
LocationHouston, TX, United States

Official product description

Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64

Why the product was recalled

Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate

Distribution information

USA Nationwide

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Telephone.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.